Sarcoidosis: An update for the primary care physician

MedGenMed Medscape General Medicine

Volumn 6, Issue 1, 2004, Pages

  Aladesanmi, Oluranti A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PENTOXIFYLLINE; THALIDOMIDE;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ETHNIC AND RACIAL GROUPS; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; LUNG DISEASE; LYMPHADENOPATHY; MASS SCREENING; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL PROFESSION; MORTALITY; PATIENT EDUCATION; POPULATION DISTRIBUTION; PREVALENCE; PRIMARY MEDICAL CARE; PROFESSIONAL PRACTICE; QUALITY OF LIFE; RISK ASSESSMENT; SARCOIDOSIS; UNITED STATES;

EID: 25144470727     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Up to Date: ATS Guidelines: Statement on Sarcoidosis. 2003. Available at: http://www.uptodateonline.com/application/topic.asp?file= ats_guid/26635&type=A&selectedTitle=5~73. Accessed Nov 1, 2003. Requires subscription.
2. Baughman RP, Teirstein AS, Judson MA, et al. A Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885-1889.
3. Hosoda Y, Yamaguchi M, Hiraga Y. Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us? Clin Chest Mede. 1997;18:681-694.
4. Gideon NM, Mannino DM. Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data. Am J Med. 1996;100:423-427.
5. Iwai K, Tachibana T, Takemura T, et al. Pathological studies on sarcoidosis autopsy. 1. Epidemiological features of 320 cases in Japan. Acta Pathol Japan. 1993;43:372-376.
6. Huang CT, Heurich AE, Sutton AL, Lyons HA. Mortality in sarcoidosis. A changing pattern of the causes of death. Eur J Respir Dis. 1981;62:231-238.
7. Reid JD. Sarcoidosis in coroner's autopsies: a critical evaluation of diagnosis and prevalence from Cuyahoga County, Ohio. Sarcoidosis Vasculitis Diffuse Lung Dis. 1998;15:44-51.
8. Henke CE, Henke G, Elveback LR, et al. The epidemiology of sarcoidosis in Rochester, Minnesota: a population based study of incidence and survival. Am J Epidemiol. 1986;123:840.
9. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234-241.
10. Reich JM. Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy. Chest. 2002;121:32-39.
11. Rybicki BA, Iannuzzi MC, Frederick MM, et al. The ACCESS Research Group. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164:2085-2091.
12. Rybicki BA, Maliarik MJ, Poisson LM, et al. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med. 2003;167:444-449.
13. Judson MA, Thompson BW, Rabin DL, et al. ACCESS Research Group. The diagnostic pathway to sarcoidosis. Chest. 2003;123:406-412.
14. Reed HM. Sarcoidosis: a multisystem disease. Minority Health Today. 2000;2:9-14.
15. Thomas KW, Hunninghake GW. Sarcoidosis. JAMA. 2003;289:3300-3303.
16. Paramothayan S, Jones PW. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA. 2002;287:1301-1307.
17. Moller DR. Treatment of sarcoidosis - from a basic science point of view. J Intern Med. 2003;253:31-40.
18. Laine C, Davidoff F, Lewis C, et al. Important elements of outpatient care: a comparison of patients' and physicians' opinions. Ann Intern Med. 1996;125:640-645.
19. Chang B, Steimel J, Moller DR, et al. Depression in sarcoidosis. Am J Respir Crit Care Med. 2001;163:329-334.
20. Donohoe MT. Comparing generalist and specialty care: discrepancies, deficiencies, and excesses. Arch Intern Med. 1998;158:1596-1608.
21. Betancourt JR, Carrillo JE, Green AR. Hypertension and minority populations: linking communication to compliance. Curr Hypertens Rep. 1999;1:482-488.
22. Cox CE, Donohue JF, Brown CD, Kataria YP, Judson MA. The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. Am J Respir Crit Care Med. 2003;168:323-329.
23. Lurking, listening, learning: using online support groups. Available at: http://www.ama-assn.org/amednews/2003/09/08/bisa0908.htm. Accessed February 24, 2004.